SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-014157
Filing Date
2021-07-21
Accepted
2021-07-21 15:50:08
Documents
3
Period of Report
2021-07-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aacceptanceoflibervantndar.htm 8-K 25032
2 EX-99.1 ex991_acceptanceoflibervan.htm EX-99.1 16519
3 imagea.jpg GRAPHIC 4479
  Complete submission text file 0001628280-21-014157.txt   48982
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 211104497
SIC: 2834 Pharmaceutical Preparations